Harrow, Inc. (HROW)
NASDAQ: HROW · Real-Time Price · USD
42.90
-0.98 (-2.23%)
Nov 22, 2024, 4:00 PM EST - Market closed
Harrow Employees
Harrow had 315 employees as of December 31, 2023. The number of employees increased by 98 or 45.16% compared to the previous year.
Employees
315
Change (1Y)
98
Growth (1Y)
45.16%
Revenue / Employee
$536,946
Profits / Employee
-$106,051
Market Cap
1.53B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
U.S. Physical Therapy | 6,720 |
Teladoc Health | 5,600 |
Certara | 1,391 |
Schrödinger | 867 |
Alphatec Holdings | 839 |
InMode | 581 |
BioCryst Pharmaceuticals | 536 |
Kiniksa Pharmaceuticals International, | 297 |
HROW News
- 2 days ago - Harrow's ImprimisRx Subsidiary Receives $34.9 Million Unanimous Jury Verdict Award in ImprimisRx, LLC v. OSRX, Inc. - Business Wire
- 8 days ago - Harrow Announces Participation in Upcoming Investor Conferences - Business Wire
- 9 days ago - Harrow, Inc. (HROW) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 10 days ago - Harrow Announces Third Quarter 2024 Financial Results - Business Wire
- 10 days ago - Harrow Launches Access and Affordability Program with Price Reductions for Branded Products - Business Wire
- 11 days ago - Harrow Announces Market Access Wins for VEVYE® - Business Wire
- 12 days ago - Harrow: VEVYE And Its Impact On The DED Market - Seeking Alpha
- 16 days ago - Harrow Partners with Asembia to Enhance Provider and Patient Experience Through Nationwide Digital Services and Hub Support for Harrow's Branded Eyecare Products - Business Wire